Get the Stockscreener App
2.04
4.62%
0.09
Hookipa Pharma Inc stock is traded at $2.04, with a volume of 73,360.
It is up +4.62% in the last 24 hours and up +0.99% over the past month.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
See More
Previous Close:
$1.95
Open:
$1.97
24h Volume:
73,360
Relative Volume:
0.61
Market Cap:
$24.59M
Revenue:
$52.16M
Net Income/Loss:
$-48.60M
P/E Ratio:
-0.4722
EPS:
-4.32
Net Cash Flow:
$-77.48M
1W Performance:
+9.68%
1M Performance:
+0.99%
6M Performance:
-68.22%
1Y Performance:
-69.10%
1-Day Range:
$1.9304
$2.07
1-Week Range:
$1.80
$2.07
52-Week Range:
$1.715
$10.50
Hookipa Pharma Inc Stock (HOOK) Company Profile
Name
Hookipa Pharma Inc
Sector
Industry
Phone
0114318906360
Address
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY
Compare HOOK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
2.04 | 24.59M | 52.16M | -48.60M | -77.48M | -4.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-15-24 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-02-22 | Downgrade | BofA Securities | Buy → Underperform |
| Nov-12-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-08-21 | Initiated | Morgan Stanley | Overweight |
| Nov-03-20 | Initiated | Truist | Buy |
| Oct-26-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-19-20 | Resumed | H.C. Wainwright | Buy |
| Sep-27-19 | Initiated | H.C. Wainwright | Buy |
| May-13-19 | Initiated | BofA/Merrill | Buy |
| May-13-19 | Initiated | RBC Capital Mkts | Outperform |
View All
Hookipa Pharma Inc Stock (HOOK) Latest News
HOOK (HOOKIPA Pharma) Shares Outstanding (EOP) : 12.05 Mil (As of Sep. 2024) - GuruFocus.com
Hookipa Pharma stock hits 52-week low at $1.73 amid market challenges - Investing.com Nigeria
Geode Capital Management LLC Cuts Stake in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
HC Wainwright Reiterates Neutral Rating for Hookipa Pharma (NASDAQ:HOOK) - Defense World
HOOKIPA Pharma explores acquisition of Poolbeg Pharma By Investing.com - Investing.com South Africa
HOOKIPA Pharma explores acquisition of Poolbeg Pharma - Investing.com
Poolbeg Pharma notes Gilead interest in Hookipa fundraise -January 10, 2025 at 11:08 am EST - Marketscreener.com
Poolbeg Pharma update on potential combination with HOOKIPA - DirectorsTalk Interviews
Poolbeg Pharma PLC (AIM:POLB) Update Potential Combination of Poolbeg & HOOKIPA - Share Talk
Poolbeg Pharma plc ('Poolbeg”) and HOOKIPA Pharma Inc. ('HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - The Manila Times
Poolbeg Pharma and HOOKIPA Explore Potential Merger Amid Gilead’s Interest - TipRanks
Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. - GlobeNewswire
Gilead Sciences Backs HOOKIPA-Poolbeg Merger Talks with $8.7M Funding Commitment - StockTitan
HOOKIPA Pharma discloses position in takeover code filing By Investing.com - Investing.com Nigeria
HOOKIPA Pharma Inc. Enters Non-Binding Discussions for Potential Acquisition of Poolbeg Pharma plc - Defense World
HOOKIPA Pharma discloses position in takeover code filing - Investing.com India
UPDATEMyriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
HOOKIPA Pharma IncFORM 8 (OPD) - GlobeNewswire
HOOKIPA Pharma Discloses Executive Stock Holdings, Awards Major RSU Grants to Leadership - StockTitan
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements - The Manila Times
HOOKIPA Pharma Issues Key Disclosure Notice for Poolbeg Pharma Acquisition Plans - StockTitan
Poolbeg and HOOKIPA progress toward potential merger By Investing.com - Investing.com Australia
HOOKIPA Pharma in talks to acquire Poolbeg Pharma By Investing.com - Investing.com Australia
HOOKIPA Pharma in talks to acquire Poolbeg Pharma - Investing.com
HOOKHOOKIPA Pharma Inc. Latest Stock News & Market Updates - StockTitan
Poolbeg and HOOKIPA progress toward potential merger - Investing.com India
Gilead backs proposed Poolbeg Pharma's proposed tie-up with HOOKIPA - Proactive Investors UK
Poolbeg and HOOKIPA Explore Potential Merger with Gilead’s Support - TipRanks
Gilead Sciences Backs Poolbeg-HOOKIPA Merger as Fundraising Target Expands to $30M+ - StockTitan
HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment - GlobeNewswire
HOOKIPA Pharma Updates Merger Talks with Poolbeg, Clarifies Post-Split Share Structure - StockTitan
State Street Corp Cuts Stake in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World
HOOKIPA Pharma Inc. in Non-Binding Discussions for Potential Acquisition of Poolbeg Pharma plc - Defense World
London-listed Poolbeg discussing Hookipa merger - pharmaphorum
Poolbeg Startles Investors With Plan To Hook Up With Hookipa - News & Insights
HOOKIPA Pharma in early talks to acquire Poolbeg - The Pharma Letter
HOOKIPA (HOOK) Shares Climb Premarket On Merger News - Stocks Telegraph
RNS Hotlist with Zak Mir: POLB, HOOK, COIN, QED, CGO, CEL, CIZ & EML - Share Talk
HOOKIPA Pharma and Poolbeg discuss all-share acquisition - DirectorsTalk Interviews
Poolbeg Pharma PLC (AIM:POLB) Combination of Poolbeg and HOOKIPA Pharma Inc. - Share Talk
Poolbeg in early talks to combine with US biotech - Proactive financial news
Hookipa Pharma Inc Stock (HOOK) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):